Abstract. The role of endogenous opioid receptors on anterior pituitary hormone secretion was evaluated by the administration of the opioid receptor antagonist naloxone. The infusion of naloxone (8 mg iv followed by 4 mg/h for 3 h) did not alter basal growth hormone (GH), prolactin (Prl) 
It has been long known that morphine and related compounds can influence pituitary hormone secre¬ tion by virtue of action on the central nervous system (Meites et al. 1979 ). The recent discovery of opiate receptors in the brain of mammals as well as the isolation of endogenous opioid-like substances (Hughes et al. 1975) , has led to considerable spe¬ culation regarding their physiological role in the control of the hypothalamus-pituitary-axis. Exogenously administered endorphins and enkephalins have been shown to affect pituitary hormone secre¬ tion in experimental animals (Bruni et al. 1977) and the reversal or attenuation of the effect by naloxone, an opiate antagonist, is taken as neuropharmacological evidence for the involvement of opiate receptors in this process.
In man, morphine raised basal prolactin (Prl) levels, but did not alter basal growth hormone (GH) and cortisol secretion (Tolis et al. 1975 ), whereas a long-acting analogue of met-enkephalin released Prl, GH and decreased gonadotrophins and cortisol (Von Graffenried et al. 1978; Stubbs et al. 1978) . The prior administration of naloxone blunted these effects (Stubbs et al. 1978 The individual pattern of LH during and 3 h after the infusion of naloxone and in the control experiment.
fusion. When naloxone was replaced by saline, cortisol mean levels were comparable to those of the control study.
There was no effect of naloxone on serum Prl, GH and TSH levels (Fig. 3) .
Dynamic studies (Cicero et al. 1976; Bruni et al. 1977 ) and naloxone competitively inhibits the effect. Similar data were obtained in man with the administration of a long-acting met-enkephalin analogue (Stubbs et al. 1978 (Rotsztejn et al. 1978) . Our additional data support the concept that endo¬ genous opioids normally inhibit the hypothalamuspituitary-gonadotrophin axis and suggest that the gonadotrophin rise may be secondary to the release to LRH from the hypothalamus rather than by an action of naloxone at the pituitary. The antagonist had no effect on the basal and LRH stimulated release of LH by the anterior pituitary in vitro (Cicero et al. 1979 ) and our observations show that naloxone does not increase the gonadotrophin response to LRH in vivo. Although the maximum LH increment observed 20 min after LRH ad¬ ministration was lower in naloxone-treated than in saline-treated subjects, basal LH levels after nalo¬ xone were higher than basal LH levels after saline and the absolute mean peak levels of gonadotrophins obtained were comparable after saline and naloxone pre-treatment. This suggests that the reduced maximum LH increment after LRH may result from a partial reduction (induced by nalo¬ xone through stimulation of endogenous LRH) of the stored gonadotrophin which is readly released after exogenous LRH injection.
Morphine has been shown to affect CRF-ACTH in experimental animals and to depress, when chronically administered, basal and stress-stimula¬ ted pituitary adrenal axis (Munson 1973) . The rise in cortisol observed after naloxone is likely to be secondary to a rise in ACTH, since we could not find any cortisol rise after naloxone in ACTHdeficient patients (unpublished data). The ability of naloxone to stimulate cortisol is in agreement with the ACTH (and cortisol) fall observed after the administration of a met-enkephalin analogue in normal subjects (Stubbs et al. 1978 ) and in patients with Addison's disease or pituitary dependent Cushing's disease (Gaillard et al. 1980) . The (Meites et al. 1979 ) and they suggest that opiate receptors suppress TSH release. In man, a single injection of morphine had no effect on TSH release (Tolis et al. 1975) , whereas metenkephalin caused a small TSH rise in normal subjects (Stubbs et al. 1978 ). More consistent data on the stimulatory role of morphine and related compounds on GH secretion are available in animal (Meites et al. 1979) 
